Anpac Bio Med Science Co. Ltd.

13F holders, Q1 2024 (March 31)
1holders
$0.55avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Anpac Bio Med Science Co. Ltd. in their 13F filings. The largest holder was Rhumbline Advisers ($4K).

Company
Anpac Bio Med Science Co. Ltd.
CUSIP
03635R206
Latest filing quarter
Q2 2024

History

Number of 13F holders

0123 Q1 2024: 1Q1 2024Q2 2024: 3Q2 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$30K

Ownership 1 holders

Rhumbline Advisers 0.00% No change 6,678 $4K

"% of holder's portfolio" is ANPAC BIO MED SCIENCE CO LTD's weight in each manager's 13F, not the share of Anpac Bio Med Science Co. Ltd. the manager owns.